Magnitude of the Disease Burden from Neurocysticercosis in a Developing Country

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 1999 Oct 19

PMID 10524964

Citations 58

Authors

C Bern

H H Garcia

C Evans

A E Gonzalez

M Verastegui

V C Tsang

R H Gilman

Affiliations

Soon will be listed here.

Abstract

Cysticercosis contributes to higher epilepsy rates in developing countries than in industrialized ones, yet no estimate exists for the associated burden of disease. We used epidemiological data on neurocysticercosis in Peru to calculate the burden of disease and applied our model to the other countries of Latin America where neurocysticercosis is endemic to determine a regional estimate. Analysis of 12 population-based community studies demonstrated that neurocysticercosis was endemic in highland areas and high jungles, with seroprevalences from 6% to 24%. In one community, the adult seizure disorder rate was 9.1% among seropositive persons versus 4. 6% among seronegative persons; we used this difference for estimates. On the basis of average prevalence rates in areas of endemicity of 6%-10%, we estimated that there are 23,512-39,186 symptomatic neurocysticercosis cases in Peru. In Latin America, an estimated 75 million persons live in areas where cysticercosis is endemic, and approximately 400,000 have symptomatic disease. Cysticercosis contributes substantially to neurological disease in Peru and in all of Latin America.

Citing Articles

Disseminated cysticercosis incidentally diagnosed in a patient with distal cholangiocarcinoma: A case report.

Poudel B, Dahal A, Rayamajhi A, Ghimire P, Roy A, Paudel S Radiol Case Rep. 2024; 19(11):4955-4962.

PMID: 39247473 PMC: 11378085. DOI: 10.1016/j.radcr.2024.07.112.

Neurocysticercosis Prevalence and Characteristics in Communities of Sinda District in Zambia: A Cross-Sectional Study.

Zulu G, Stelzle D, Gabriel S, Trevisan C, Van Damme I, Mubanga C J Epidemiol Glob Health. 2024; 14(3):1180-1190.

PMID: 38980629 PMC: 11444043. DOI: 10.1007/s44197-024-00271-z.

Top-50 cited articles on cysticercosis and neurocysticercosis.

Gonzalez-Alcaide G, Sosa N, Valero-Samper F, Belinchon-Romero I, Ramos-Rincon J Medicine (Baltimore). 2024; 103(9):e37268.

PMID: 38428894 PMC: 10906643. DOI: 10.1097/MD.0000000000037268.

Serological and molecular detection of neurocysticercosis among epileptic patients in Nagpur, Maharashtra state (India).

Satyaprakash K, Khan W, Zade N, Chaudhari S, Shinde S, Kurkure N Helminthologia. 2023; 60(3):208-220.

PMID: 38152476 PMC: 10750244. DOI: 10.2478/helm-2023-0023.

Multiantigen print immunoassay (MAPIA) for the diagnosis of neurocysticercosis: a single-center diagnostic optimization and accuracy study in Lima, Peru.

Toribio L, Guzman C, Noazin S, Zimic-Sheen A, Zimic M, Gonzales I J Clin Microbiol. 2023; 61(12):e0076023.

PMID: 37966225 PMC: 10729656. DOI: 10.1128/jcm.00760-23.

References

Sakai H, Sone M, Castro D, Nonaka N, Quan D, Canales M . Seroprevalence of Taenia solium cysticercosis in pigs in a rural community of Honduras. Vet Parasitol. 1998; 78(3):233-8. DOI: 10.1016/s0304-4017(98)00144-7. View

Del Brutto O, Santibanez R, Noboa C, Aguirre R, Diaz E, Alarcon T . Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology. 1992; 42(2):389-92. DOI: 10.1212/wnl.42.2.389. View

Garcia H, Herrera G, Gilman R, Tsang V, Pilcher J, Diaz J . Discrepancies between cerebral computed tomography and western blot in the diagnosis of neurocysticercosis. The Cysticercosis Working Group in Peru (Clinical Studies Coordination Board). Am J Trop Med Hyg. 1994; 50(2):152-7. DOI: 10.4269/ajtmh.1994.50.152. View

Senanayake N, Roman G . Epidemiology of epilepsy in developing countries. Bull World Health Organ. 1993; 71(2):247-58. PMC: 2393447. View

Allan J, Fletes C, Yurrita P, Soto de Alfaro H, Rivera A . Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs. Trans R Soc Trop Med Hyg. 1998; 91(5):595-8. DOI: 10.1016/s0035-9203(97)90042-0. View

Placencia M, Farmer P, Jumbo L, Sander J, Shorvon S . Levels of stigmatization of patients with previously untreated epilepsy in northern Ecuador. Neuroepidemiology. 1995; 14(3):147-54. DOI: 10.1159/000109790. View

Del Brutto O, Wadia N, Dumas M, Cruz M, Tsang V, Schantz P . Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 1996; 142(1-2):1-6. DOI: 10.1016/0022-510x(96)00130-x. View

Diaz J, Verastegui M, Gilman R, Tsang V, Pilcher J, Gallo C . Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. The Cysticercosis Working.... Am J Trop Med Hyg. 1992; 46(5):610-5. DOI: 10.4269/ajtmh.1992.46.610. View

Tsang V, Brand J, Boyer A . An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis. 1989; 159(1):50-9. DOI: 10.1093/infdis/159.1.50. View

10.

Newell E, Vyungimana F, Geerts S, van Kerckhoven I, Tsang V, Engels D . Prevalence of cysticercosis in epileptics and members of their families in Burundi. Trans R Soc Trop Med Hyg. 1997; 91(4):389-91. DOI: 10.1016/s0035-9203(97)90251-0. View

11.

Padma M, Behari M, Misra N, Ahuja G . Albendazole in neurocysticercosis. Natl Med J India. 1995; 8(6):255-8. View

12.

. The marketing of cysticercotic pigs in the Sierra of Peru. The Cysticercosis Working Group in Peru. Bull World Health Organ. 1993; 71(2):223-8. PMC: 2393460. View

13.

Monteiro L, Coelho T, Stocker A . Neurocysticercosis--a review of 231 cases. Infection. 1992; 20(2):61-5. DOI: 10.1007/BF01711064. View

14.

Placencia M, Shorvon S, Paredes V, Bimos C, Sander J, Suarez J . Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. Brain. 1992; 115 ( Pt 3):771-82. DOI: 10.1093/brain/115.3.771. View

15.

Garcia H, Martinez M, Gilman R, Herrera G, Tsang V, Pilcher J . Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru. Lancet. 1991; 338(8766):549-51. PMC: 2913119. View

16.

Bending J, Catford J . Epidemic of burns in New Guinea due to cerebral cysticercosis. Lancet. 1983; 1(8330):922. DOI: 10.1016/s0140-6736(83)91343-0. View

17.

Diaz F, Garcia H, Gilman R, Gonzales A, Castro M, Tsang V . Epidemiology of taeniasis and cysticercosis in a Peruvian village. The Cysticercosis Working Group in Peru. Am J Epidemiol. 1992; 135(8):875-82. PMC: 3103216. DOI: 10.1093/oxfordjournals.aje.a116383. View

18.

Rodriguez-Canul R, Allan J, Dominguez J, Villegas S, Cob L, Rodriguez R . Application of an immunoassay to determine risk factors associated with porcine cysticercosis in rural areas of Yucatan, Mexico. Vet Parasitol. 1998; 79(2):165-80. DOI: 10.1016/s0304-4017(98)00161-7. View

19.

Baranwal A, Singhi P, Khandelwal N, Singhi S . Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J. 1998; 17(8):696-700. DOI: 10.1097/00006454-199808000-00007. View

20.

Sarti E, Schantz P, Plancarte A, Wilson M, Gutierrez O, Aguilera J . Epidemiological investigation of Taenia solium taeniasis and cysticercosis in a rural village of Michoacan state, Mexico. Trans R Soc Trop Med Hyg. 1994; 88(1):49-52. DOI: 10.1016/0035-9203(94)90493-6. View